🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhongyan Hua

China Medical University

ORCID: 0000-0002-6885-2221

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells”.

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells

Frontiers in Oncology(2021)10.3389/fonc.2021.686898

N/A

0DataRank · unranked

3 citations

Jinhua Zhang, Zhongyan Hua, Zhihui Liu, Carol J. Thiele, Zhijie Li +1 more

Downregulation of Fibronectin 1 Attenuates ATRA-induced Inhibition of Cell Migration and Invasion in Neuroblastoma Cells

Research Square(2021)10.21203/rs.3.rs-189238/v1

N/A

0DataRank · unranked

0 citations

Wei Gong, Bo Chen, Baocheng Gong, Zhongyan Hua, Simeng Zhang +4 more

FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1384141

N/A

0DataRank · unranked

3 citations

Zhongyan Hua, Zhijie Li, Mei‐Zhen Lin